This enables rapid turnaround of new peptide designs as well as cost effective scale-up ... and Zadaxin - drugs used primarily to treat Osteoporosis and Hepatitis B respectively. They leveraged this ...

“These de novo design peptides are cyclic-composed of non-natural amino acids and are the third generation of peptide therapeutics,” Lerner said. “The new generation of peptide drugs ...

“I am very proud of this work and the results achieved and now that it’s published, I hope it is the beginning of a great new future for therapeutic peptides,” she said. The team expects the ...

Peptides are amino acid polymers. They are generally much smaller than proteins and don’t have sufficient activity on their own – they generally represent a small portion of a full protein.